The IMID Forum

EULAR 2024 Highlights: Day 2

13 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of EULAR 2024 (Thursday, June 13).

EULAR 2024 Highlights: Day 1

12 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Wednesday, June 12).

EULAR 2024 Preview Podcast

10 Jun 2024

Contributed by Lukas

Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they guide you through their top selections in RA, PsA, and axSpA...

Discussing RA: May 2024

06 Jun 2024

Contributed by Lukas

Join Professor Iain McInnes and guests Professor Janet Pope and Dr Sofia Ramiro for the latest episode on The Immune-Mediated Inflammatory Disease For...

IMID Author Interview: Dorthe Berthelsen, 2024

14 May 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dorthe Berthelsen, a PhD student and physiotherapist at the Parker Institute i...

Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases

07 May 2024

Contributed by Lukas

Webinar Highlights Podcast: Join Professor Iain McInnes and Associate Professor Laura Coates on the Immune-Mediated Inflammatory Disease Forum in thei...

IMID Author Interview: Dr Jake Weddell, 2024

07 May 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jake Weddell, an academic rheumatology trainee at Leeds Teaching Hospitals...

IMID Author Interview: Professor Frank Verhoeven, 2024

30 Apr 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Frank Verhoeven, an Assistant Professor in Rheumatology at the CHU B...

Discussing RA: April 2024

25 Apr 2024

Contributed by Lukas

Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and da...

Author Interview: Professor Maria Antonietta D’Agostino, 2024

18 Apr 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Maria Antonietta D’Agostino, the Head of the Rheumatology Department at the ...

Author Interview: Professor Dennis McGonagle, 2024

16 Apr 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Dennis McGonagle, a Clinical Professor at the University of Leeds Sc...

Author Interview: Dr Jürgen Rech, 2024

04 Apr 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jürgen Rech, a Senior Physician at the Friedrich-Alexander University of E...

Author Interview: Dr Mahta Mortezavi, 2024

28 Feb 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Mahta Mortezavi, a Clinical Director for Drug Discovery and Early Developme...

Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs

26 Feb 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, as well as Professors Andrew Cope, Professor of Rheumatology and Head of the Centr...

Author Interview: Dr Kehinde Sunmboye, 2024

15 Feb 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Kehinde Sunmboye, a consultant rheumatologist at the University Hospitals o...

Author Interview: Professor Andrea Rubbert-Roth, 2023

22 Jan 2024

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrea Rubbert-Roth, a doctor of rheumatology and internal medicine ...

Discussing Rheumatology: December 2023

22 Dec 2023

Contributed by Lukas

Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he discu...

PsA Podcast: Impact of Biological Sex on Advanced Therapies & Upadacitinib-related Malignancies

22 Dec 2023

Contributed by Lukas

Join Philip Mease, Professor at the University of Washington School of Medicine and Director of Rheumatology Research at the Swedish Medical Centre in...

AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab

04 Dec 2023

Contributed by Lukas

Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world o...

AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab

01 Dec 2023

Contributed by Lukas

Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world o...

PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA

01 Dec 2023

Contributed by Lukas

Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Austr...

Discussing Rheumatology: November 2023

23 Nov 2023

Contributed by Lukas

Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he discu...

ACR 2023 Highlights: Day 4

15 Nov 2023

Contributed by Lukas

Join Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Wednesday 15 November). They're all...

ACR 2023 Highlights: Day 3

14 Nov 2023

Contributed by Lukas

Join Grace Wright as she goes through our top abstracts, posters, and presentations from Day 3 of ACR 2023 today (Tuesday 14 November). They're all a...

ACR 2023 Highlights: Day 2

13 Nov 2023

Contributed by Lukas

Join Laura Coates as she goes through our top abstracts, posters, and presentations from Day 2 of ACR 2023 today (Monday 13 November). They're all av...

ACR 2023 Highlights: Day 1

12 Nov 2023

Contributed by Lukas

Join Iain McInnes as he goes through our top abstracts, posters, and presentations from Day 1 of ACR 2023 today (Sunday 12 November). They're all ava...

ACR 2023 Preview Podcast

09 Nov 2023

Contributed by Lukas

Join Dr Sofia Ramiro as she previews our highlights this ACR, introducing some of the top abstracts and posters we’ve chosen so that you can better ...

Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA

31 Oct 2023

Contributed by Lukas

Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Austr...

axSpA Podcast: Safety and Efficacy of Upadacitinib

26 Oct 2023

Contributed by Lukas

Professor Hideto Kameda, Professor of Internal Medicine at Toho University in Japan, is joined by Professor Xenofon Baraliakos, Professor of Internal ...

CSF Author Interview: Dr. David Martin, 2023

26 Oct 2023

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane, and Dr. David Martin, executive medical director at Pfizer in Massachusetts, USA a...

Discussing Rheumatology: October 2023

20 Oct 2023

Contributed by Lukas

Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology. In this episode, he dis...

EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer

16 Oct 2023

Contributed by Lukas

Join Professor Peter Nash from the Griffith University in Brisbane and Dr. Andreas Kerschbaumer of the Division of Rheumatology, Department of Interna...

CSF Author Interview: Professor Martin Bergman, 2023

11 Oct 2023

Contributed by Lukas

Professor Peter Nash from the Griffith University in Brisbane, is joined by Professor Martin Bergman, a Clinical Associate Professor of Medicine at th...

Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA

11 Oct 2023

Contributed by Lukas

Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia,...

AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab

25 Sep 2023

Contributed by Lukas

Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Zuyderland Medical Centre and Leiden University Medical Centre in the Netherlands,...

Discussing Rheumatology: September 2023

25 Sep 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers , that retrospectively investigate the properties of JAK inhibitors. In our first paper,...

Author Interview: Sofia Ramiro

31 Aug 2023

Contributed by Lukas

Professor Peter Nash from the Griffith University in Brisbane, is joined by Doctor Sofia Ramiro, a Consultant Rheumatologist and Senior Researcher at ...

Discussing Rheumatology: August 2023

22 Aug 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Charles-Schoeman and colleagues compared paraoxonase activity...

AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue

16 Aug 2023

Contributed by Lukas

Join Professor Hideto Kameda, and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition, our Steering Committee members di...

Discussing Rheumatology: July 2023

19 Jul 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Roy Fleischmann and his colleagues compares the incidence of ...

PsA Podcast: Secukinumab in Oligoarticular PsA & JAK Inhibition-related Malignancies

12 Jul 2023

Contributed by Lukas

Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Austr...

Author Interview: Laura Coates

10 Jul 2023

Contributed by Lukas

Professor Peter Nash from the Griffith University in Brisbane, is joined by Professor Laura Coates a NIHR clinician scientist and senior clinical rese...

Author Interview: Mark Russell

07 Jul 2023

Contributed by Lukas

Professor Peter Nash from the Griffith University in Brisbane, is joined by Dr Mark Russell, a clinical research fellow at the Centre for Rheumatic Di...

Discussing Rheumatology: June 2023

26 Jun 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers surrounding filgotinib and baricitinib. Our first paper today by Walter Reinisch and his c...

AxSpA Podcast: Secukinumab Optimisation & Ixekizumab Treatment for PAEs

14 Jun 2023

Contributed by Lukas

Join Professors Atul Deodhar, Xenofon Baraliakos, Hideto Kameda, and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition...

EULAR 2023 Highlights: Day 4

03 Jun 2023

Contributed by Lukas

Join Professor Peter Nash as he goes through our top abstracts, posters, and presentations from Day 4 of EULAR 2023 today (Saturday 3 June). They're ...

EULAR 2023 Highlights: Day 3

02 Jun 2023

Contributed by Lukas

Join Professor Lorenzo Dagna as she goes through our top abstracts, posters, and presentations from Day 3 of EULAR 2023 today (Friday 2 June). They'r...

EULAR 2023 Highlights: Day 2

01 Jun 2023

Contributed by Lukas

Join Dr Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 2 of EULAR 2023 today (Thursday 1st June). They're al...

Discussing Rheumatology: May 2023

31 May 2023

Contributed by Lukas

Join Prof Iain McInnes in today’s podcast, where he will be reviewing two papers that investigate treatments for RA patients. In the first paper, ...

EULAR 2023 Highlights: Day 1

31 May 2023

Contributed by Lukas

Join Professor Xavier Mariette as he goes through our top abstracts, posters, and presentations from Day 1 of EULAR 2023 today (Wednesday 31 May). Th...

EULAR 2023 Preview Podcast

26 May 2023

Contributed by Lukas

Join Professor Peter Nash as he previews our highlights this EULAR, introducing some of the top abstracts we’ve chosen so that you can better plan y...

PsA Podcast: Guselkumab & Secukinumab – All the Latest in Efficacy & Safety

15 May 2023

Contributed by Lukas

Join Professors Peter Nash, Laura Coates, and Frank Behrens as they discuss the latest top research in PsA. The papers covered in this topical discus...

Author Interview: Shikha Singla

28 Apr 2023

Contributed by Lukas

Dr Shikha Singla, Assistant Professor of Medicine at the Medical College of Wisconsin where she is also Medical Director of the psoriatic arthritis pr...

AxSpA Podcast: AS Associated MACE & Upadacitinib's Long Term Safety

19 Apr 2023

Contributed by Lukas

Join Dr. Sofia Ramiro and Professor Hideto Kameda as they discuss the latest top research in axSpA. In this edition, our Steering Committee members di...

Discussing Rheumatology: April 2023

12 Apr 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers that help to broaden our understanding and knowledge on the safety of biologic and targete...

PsA Podcast: Herpes Zoster In JAK Inhibitor Therapies & The APEX Protocol

31 Mar 2023

Contributed by Lukas

Join Professors Iain McInnes, Laura Coates, and Peter Nash as they discuss the latest top research in PsA. The first paper we will discuss aimed to sy...

Discussing Rheumatology: March 2023

30 Mar 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. In the first of today’s papers, Jeffrey Curtis and colleagues aimed to evaluate maligna...

Author Interview: Charis Meng

03 Mar 2023

Contributed by Lukas

Dr. Charis Meng, a rheumatologist at the Hospital for Special Surgery and Assistant Professor at Weill Cornell Medical College in New York. In this ed...

Discussing Rheumatology: February 2023

23 Feb 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. In the first paper, Professor Maxime Dougados and colleagues shed some more light into th...

Discussing AxSpA: Episode 5

08 Feb 2023

Contributed by Lukas

Join Professors Atul Deodhar, Hideto Kameda, Xenofon Baraliakos and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition,...

Discussing Rheumatology: January 2023

02 Feb 2023

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. In the first paper the authors cover aspects from mean disease activity scores after tape...

Author Interview: Kevin Winthrop

01 Feb 2023

Contributed by Lukas

Professor Kevin Winthrop, Professor of Infectious Diseases, Public Health and Preventive Medicine, and Ophthalmology, from Oregon Health and Science U...

Discussing PsA: Episode 5

26 Jan 2023

Contributed by Lukas

Join Professor Philip Mease and Dr Frank Behrens as they discuss the latest top research in PsA. In this edition, our Steering Committee members look ...

Author Interview: Rebecca Haberman

25 Jan 2023

Contributed by Lukas

Dr Rebecca Haberman from the Department of Medicine, Division of Rheumatology, New York University Grossman School of Medicine and Psoriatic Arthritis...

Author Interview: Roy Fleischmann

18 Jan 2023

Contributed by Lukas

Professor Roy Fleischmann, Clinical Professor of Medicine at the University of Texas Southwestern Medical Centre. In this addition Professor Fleischma...

Author Interview: Claudia Salinas

13 Jan 2023

Contributed by Lukas

Dr Claudia Salinas, Director Pharmacoepidemiology at Eli Lilly and Company, Indianapolis, USA. In this addition Dr Salinas discusses her recent paper ...

Discussing Rheumatology: December 2022

23 Dec 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. The first highlights one of the three systematic literature reviews carried out to inform...

Discussing AxSpA: Episode 4

14 Dec 2022

Contributed by Lukas

Join Professor Xenofon Baraliakos and Dr Sofia Ramiro as they discuss the latest top research in axSpA. In this edition, our Steering Committee member...

Discussing Rheumatology: November 2022

24 Nov 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. The first paper aimed to compare the risk of MACEs and VTEs for patients initiating a JAK...

Discussing PsA: Episode 4

09 Nov 2022

Contributed by Lukas

Join Professor Iain McInnes and Dr Frank Behrens as they discuss the latest top research in PsA. In this edition, our Steering Committee members look...

Discussing Rheumatology: October 2022

28 Oct 2022

Contributed by Lukas

Discussing Rheumatology: October 2022 by The Immune-Mediated Inflammatory Disease Forum

Discussing AxSpA: Episode 3

12 Oct 2022

Contributed by Lukas

Join Professors Iain McInnes and Hideto Kameda as they discuss the latest top research in axSpA. In this edition, our Steering Committee members discu...

Discussing Rheumatology: September 2022

28 Sep 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. The first covers the impact of initial therapy with upadacitinib or adalimumab on achieve...

Author Interview: Eduardo Mysler

28 Sep 2022

Contributed by Lukas

Dr Eduardo Mysler, from the School of Medicine, University of Buenos Aires, Argentina. Join Professor Peter Nash as he interviews authors of recent no...

Discussing PsA: Episode 3

13 Sep 2022

Contributed by Lukas

Join Professors Iain McInnes and Phillip Mease as well as Doctors Frank Behrens and Laura Coates as they discuss the latest top research in PsA. In t...

Author Interview: Ameen Jubber

22 Aug 2022

Contributed by Lukas

Dr Ameen Jubber, specialist registrar in rheumatology at the University Hospitals of Leicester NHS Trust, in the UK. Join Professor Peter Nash as he i...

CSF Monthly Podcast August22

22 Aug 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers. The first covers new data from China on the first-in-human trial of KL130008. The second ...

Author Interview: Kim Lauper

10 Aug 2022

Contributed by Lukas

Dr Kim Lauper, from the Division of Rheumatology, Department of Internal Medicine and Department of Medicine, Faculty of Medicine, Geneva University H...

Discussing AxSpA: Episode 2

08 Aug 2022

Contributed by Lukas

Join Prof. Baraliakos and Dr Mehta as they discuss the latest top research in axSpA. In this edition, our Steering Committee members look at three key...

Discussing Rheumatology: July 2022

28 Jul 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers from May and June. The first -by Faquetti , et al.- provides some insightful information i...

Discussing PsA: Episode 2

27 Jul 2022

Contributed by Lukas

Join Professors McInnes and Nash as they discuss the latest top research in PsA. In this edition, our Steering Committee members look at three key pap...

Author Interview: Diego Kyburz

25 Jul 2022

Contributed by Lukas

Author Interview: Diego Kyburz by The Immune-Mediated Inflammatory Disease Forum

Discussing Rheumatology: June 2022

18 Jul 2022

Contributed by Lukas

Discussing Rheumatology: June 2022 by The Immune-Mediated Inflammatory Disease Forum

Discussing axSpA: Episode 1

24 Jun 2022

Contributed by Lukas

Discussing axSpA: Episode 1 by The Immune-Mediated Inflammatory Disease Forum

Discussing PsA: Episode 1

07 Jun 2022

Contributed by Lukas

Join Dr Laura Coates, Prof Enrique Soriano, Prof Chris Ritchlin, and Ass Prof Frank Behrens for our first podcast dedicated to the latest publications...

DAY 4: EULAR 2022 Daily Highlights

04 Jun 2022

Contributed by Lukas

Douglas Veale takes you through our top picks from the selection of abstracts presented at the final day of EULAR 2022 (Saturday 4 June). Today's podc...

DAY 3: EULAR 2022 Daily Highlights

03 Jun 2022

Contributed by Lukas

Douglas Veale takes you through our top picks from the selection of abstracts at EULAR 2022 today (Friday 3 June). Today's podcast covers RA, PsA, and...

DAY 2: EULAR 2022 Daily Highlights

02 Jun 2022

Contributed by Lukas

Laura Coates takes you through our top picks from the selection of abstracts at EULAR 2022 today (Thursday 2 June). Today's podcast covers RA, PsA, an...

DAY 1, PsA: EULAR 2022 Daily Highlights

01 Jun 2022

Contributed by Lukas

Laura Coates takes you through our top picks from the selection of psoriatic arthritis abstracts at EULAR 2022 today (Wednesday 1 June). Today's abstr...

DAY 1, RA: EULAR 2022 Daily Highlights

01 Jun 2022

Contributed by Lukas

Laura Coates takes you through our top picks from the selection of rheumatoid arthritis abstracts at EULAR 2022 today (Wednesday 1 June). Today's ab...

DAY 1, axSpA: EULAR 2022 Daily Highlights

01 Jun 2022

Contributed by Lukas

Laura Coates takes you through our top picks from the selection of axial spondyloarthritis abstracts at EULAR 2022 today (Wednesday 1 June). Today's a...

EULAR 2022 Preview Podcast

27 May 2022

Contributed by Lukas

EULAR 2022 Preview Podcast by The Immune-Mediated Inflammatory Disease Forum

Discussing Rheumatology: May 2022

25 May 2022

Contributed by Lukas

Join Prof Iain McInnes as he reviews two interesting papers published in May 2022! The first – from Bartlett et al – looks at the impact of tofac...

Author Interview: Professor Peter Taylor

28 Apr 2022

Contributed by Lukas

Professor Peter Taylor, from the University of Oxford in the UK. Join Professor Peter Nash as he interviews authors of recent notable papers in rheuma...

Discussing Rheumatology: Pain, pneumonia and perspectives

28 Apr 2022

Contributed by Lukas

Prof Iain McInnes reviews three papers this month!. The first – from Taylor et al – looks at pain control in early RA treated with baricitinib, th...

Author Interview: Professor Rüdiger Müller

12 Apr 2022

Contributed by Lukas

Professor Rüdiger Müller, Rheumazentrum Ostschweiz, Switzerland. Join Professor Peter Nash as he interviews authors of recent notable papers in rheu...

Discussing Rheumatology: March 2022

12 Apr 2022

Contributed by Lukas

Discussing Rheumatology: March 2022 by The Immune-Mediated Inflammatory Disease Forum

Author Interview: Professor Roy Fleischmann

16 Mar 2022

Contributed by Lukas

Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas. Join Professor Peter Nash as he interviews authors of r...

Discussing Rheumatology: Tofacitinib safety and dose-switching in RA

24 Feb 2022

Contributed by Lukas

Prof Iain McInnes reviews two papers this month, both on tofacitinib. The first looks at CV outcomes from the STAR-RA study, the second is a post-hoc ...

ACR1540 Ana Rita Cruz - Machado

11 Feb 2022

Contributed by Lukas

ACR1540 Ana Rita Cruz - Machado by The Immune-Mediated Inflammatory Disease Forum